
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading research institution in Bristol is seeking a Computational Drug Design Scientist to pioneer innovative therapies through advanced molecular modeling and AI. The role requires a team-oriented individual with expertise in drug design and structural biology. The compensation package ranges from £55k to £75k, combining salary and share options, and the organization supports flexible remote work with opportunities for in-person collaboration in London and Cambridge.
University of Bristol, Bristol, United Kingdom
Kuano is pioneering new approaches to computational drug design, bringing quantuminsights, molecular modeling and AI together to help discover and optimise novel smallmolecule medicines. The vision is for physics based approaches to act as “world models”,
enhancing data driven technologies, enabling the creation of innovative therapies for targets that are currently deemed undruggable. They are seeking a highly motivated and enthusiastic scientist to join our multidisciplinary team. This role offers the opportunity to work at the
exciting crossroads of:
The successful candidate will lead internal and client-facing projects, taking responsibility for translating complex requirements into actionable modelling plans that impact drug design decision makers. This role combines hands‑on execution of simulation and data analysis campaigns, overseeing collaborative projects and working with the technical team to build and adapt scalable workflows to enhance drug design.
To apply contacthr@kuano.aiwith your CV.
Join the team in pursuing ambitious goals—all candidates welcome with experience or the potential to grow into the role. The compensation package combines salary and share options, with remuneration expected to be between £55k and £75k.
Since the inception, Kuano has operated primarily as a remote organisation. Their are now excited to expand our collaborative in‑person work, with hubs in London and Cambridge, while continuing to embrace the flexibility of remote working.